阿特斯 reported revenue of ¥12.78B for the period ended 2026-06-30, -39.3% year on year. Net income was ¥0.32B, a 2.5% net margin on a 14.5% gross margin. The largest revenue line is 储能系统业务 at 44% of the total. Free cash flow for the period was ¥-1.33B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥12.78B | -39.3% |
| Gross profit | ¥1.85B | — |
| Operating income | ¥0.62B | — |
| Net income | ¥0.32B | -56.3% |
| Gross margin | 14.5% | Net margin 2.5% |
| Revenue Q/Q | -20.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 储能系统业务 | ¥5.66B | 44.3% |
| 光伏组件产品收入 | ¥3.79B | 29.7% |
| 其他(补充) | ¥2.80B | 21.9% |
| 光伏系统产品收入 | ¥0.46B | 3.6% |
| 建造合同收入 | ¥0.07B | 0.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥10.93B | 85.5% |
| R&D | ¥0.28B | 2.2% |
| SG&A | ¥0.99B | 7.7% |
| Tax & other | ¥0.30B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥60.08B |
| Total liabilities | ¥37.29B |
| Shareholders' equity | ¥22.79B |
| Equity / assets | 37.9% |
| Operating cash flow | ¥-0.74B |
| Capital expenditure | ¥0.60B |
| Free cash flow | ¥-1.33B |
| Cash conversion (OCF / net income) | -277% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies